$MYO

KIRK THOMAS F purchased $51K of MYO

KIRK THOMAS F purchased 40,002 shares of MYOMO, INC. (MYO) at $1.27 on 2026-06-05.

Original reporting
SEC EDGAR · KIRK THOMAS F
Published Jun 9, 2026, 8:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2026, 8:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MYO
Bullish
low confidence
Mentioned
$MYO
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MYOBullishLow
01

Why it matters

The newest fact is the director’s open-market purchase details (shares, price, and post-transaction holdings).

02

Market read

Provides a fresh insider-buy datapoint that may slightly influence sentiment, but lacks fundamental company catalysts.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan; traders may still discount the signal because the disclosed dollar amount is relatively small versus typical institutional flows.

Relevance 4/10Novelty 6/10Timing: Filed 2026-06-09 (transaction dated 2026-06-05)

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Myomo, Inc.

Company-level read

Ticker impact

$MYOBullishLow confidence
Context

Myomo director Kirk Thomas F filed an open-market purchase of 40,002 shares at $1.27 on 2026-06-05 (Form 4).

Expected impact

Likely limited near-term impact; any effect should be small and sentiment-driven.

Evidence & confidence

This is a Form 4 insider transaction with modest disclosed value (~$50.8k) and no accompanying company-specific operational or financial news.

Market effects

No clear sector read-through from a single small insider buy.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine diversification/compensation-related or driven by personal liquidity needs rather than a strong forward view.

Key entities

  • MYOMO, INC.

    Subject of the Form 4 insider transaction disclosure.

  • KIRK THOMAS F

    Director who purchased 40,002 shares open-market at $1.27 on 2026-06-05.

Related articles

$MYOHigh

MYOMO, INC. (MYO): Results of Operations and Financial Condition

MYOMO, INC. (MYO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 myo-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Myomo Reports Second Quarter 2026 Financial and Operating Results Revenue of $11.7 million, increased 21% year over year Four success pillars driving higher revenue growth and operating leverage Raising full year revenue guida

$RGNTMedAI 8/10

Top Biotech Gainers: RGNT Withdraws F-1 Filing, FDA Clears CUPR's Maggot Therapy, MYO On Watch

Regentis (RGNT) shares rose 526.7% after it withdrew a planned SEC Form F-1 for a firm-commitment offering of 3.33M shares at an assumed $3.00. Cuprina (CUPR) jumped 111.8% after FDA clearance for MEDIFLY maggots for debridement of non-healing wounds. Intellia (NTLA) gained 23.2% on additional Phase 3 results for hereditary angioedema; it targets approval and a 1H 2027 launch.